SURGICAL INNOVATIONS GROUP PLC

Share Issue/Capital Change • Sep 27, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0145O

Surgical Innovations Group PLC

27 September 2019

27 September 2019

Surgical Innovations Group plc 

("SI Group" or "the Company")

Exercise of Options, Issue of Equity & Total Voting Rights

Exercise of Options

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces that it has today issued and allotted a total of 4,750,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") following an exercise of options.

Application has been made to the London Stock Exchange for the 4,750,000 Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective at 8.00 a.m. on 3 October 2019.

Total Voting Rights

Following Admission, the Company will have 795,316,177 Ordinary Shares in issue with each share carrying the right to one vote. The Company has no Ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 795,316,177.

For further information please contact:

Surgical Innovations Group Plc	www.sigroupplc.com
Nigel Rogers, Non-Executive Chairman	Tel: 0113 230 7597
Charmaine Day, Company Secretary & GFC
N+1 Singer  (Nominated Advisor and Broker) Richard Lindley	Tel: 020 7496 3000
Rachel Hayes
Walbrook PR (Financial PR & Investor Relations)	Tel: 020 7933 8780 or si@walbrookpr.com
Paul McManus Lianne Cawthorne	Mob: 07980 541 893 Mob: 07584 391 303

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRLLFVSARIDFIA